About the 340B Drug Pricing Program
Since 1992, 340B has enabled safety-net organizations to manage rising prescription drug costs for vulnerable populations. The federal program requires pharmaceutical manufacturers participating in Medicaid to lower drug costs for low-income patients. With 340B, organizations can invest savings into vital resources, such as vaccines or mental health care programs.
Eligibility requirements
To participate in the 340B Drug Pricing Program, organizations must comply with the strict requirements set by the U.S. Health Resources and Services Administration. These requirements include:
- Keeping Office of Pharmacy Affairs Information
- System (OPAIS) records updated and accurate
- Re-certifying program eligibility on an annual basis
- Preventing diversion of medication to ineligible patients
- Preventing duplicate manufacturers discounts
- Maintaining records and documents for program audits
Partnering with Genoa
When you partner with Genoa for 340B benefits, you get:
- Best-in-class pricing
- A dedicated pharmacy that serves your clinic’s needs and aligns with your team’s values
- Capabilities of a national pharmacy with the personal touch of a local one
- Superior adherence rates and better outcomes for consumers
- Reduced operational risk
- Increased oversight of consumer outcomes
- A dedicated account manager
- More time to focus on clinical operations and outcomes
- Maximized shared cost savings
Meet FQHC standards
As a Federally Qualified Health Center (FQHC), you’re required to meet rigorous standards. Genoa helps centers across the country do just that by:
- Increasing medication-adherence rates and offering data to back it up
- Growing the comprehensive service offerings to consumers
- Maximizing reimbursements and overall profits
More information about 340B requirements can be found on the HRSA website.
340B program resources
340B 101: What your clinic needs to know
340B made easy: 5 traits to look for in a pharmacy partner
